News
Seeing the Invisible: How Tiny “Tumorlets” Could Change Our Understanding of Small Intestinal Neuroendocrine Tumors
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we fund research that can change how neuroendocrine cancers
NETRF Launches First Early Detection Research Funding Opportunity
Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not
Where Thrivership Meets Cancer Research: A Patient Perspective
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as
A View from AACR: Keeping Neuroendocrine Cancer in the Conversation
By Anna C. Greene, PhD, NETRF Chief Scientific Officer The American Association for Cancer Research Annual Meeting, known as AACR, is one of the largest
You Ask, NETRF Answers: Why Does It Take So Long to Diagnose a NET?
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, Chief Scientific Officer, Neuroendocrine Tumor Research Foundation (NETRF) You asked.
How One 15 Year-Old Is Channeling Creativity Into Support for Neuroendocrine Cancer Research
Leo Giancola lost his mom Ivette Giancola to neuroendocrine cancer when he was still in kindergarten. While his memories of her at that age are
Your Support Is Changing What’s Possible for Neuroendocrine Cancer
When we launched Breakthroughs Today, Cures Tomorrow, we made a promise: to accelerate the science that leads to better treatments and, ultimately, cures for neuroendocrine
Your Insights Are Shaping Know Your NETs 2026
More than 1,100 patients and caregivers from across the United States and internationally participated in NETRF’s 2026 Annual Patient and Caregiver Survey, sharing their experiences,
NETRF Research Round-Up: Two New Studies Illuminating NET Biology
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
A Duck Egg Model Offers a New Way to Study Neuroendocrine Tumors
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by